USCarePharm Co., Ltd., a leading innovator in bio-based functional ingredients, will unveil its latest research on vascular anti-aging and health-supporting materials at the 53rd Annual General Meeting & Scientific Conference of the Korean Society of Pharmacognosy, to be held on November 3–4 at Ewha Womans University ECC.

The company will present preclinical study results on USCP-GHV-014, a proprietary natural material demonstrating significant efficacy in reducing intimal-medial thickness (IMT) and inhibiting collagen deposition in blood vessels. The findings suggest preserved vascular elasticity and reduced pulse pressure, both crucial indicators for cardiovascular health.

As vascular aging begins as early as in the 20s, structural stiffening of arterial walls and loss of elasticity increase pulse pressure — the difference between systolic and diastolic blood pressure. This pressure widening is a strong predictor of cardiovascular risk. Given the rise in vascular-related concerns among younger populations due to high-fat diets, sedentary lifestyles, and chronic stress, proactive vascular care has become essential across all age groups.

“We are proud to present the promising preclinical data of USCP-GHV-014 in preventing vascular aging at this prestigious conference,” said CEO Song Seok-jin of USCarePharm.
“Following successful human application trials, we aim to open a new frontier in the vascular wellness market with scientifically validated and systematically developed natural health ingredients.”

USCP-GHV-014 is being developed under the High Value-Added Food Technology Development Program, supported by the Korea Institute of Planning and Evaluation for Technology in Food, Agriculture, and Forestry (IPET). The company is also pursuing intellectual property rights to protect its novel formulation.